ArticleJCEM case reports2025
Severely Dilated Cardiomyopathy and Cardiogenic Shock in a Patient With Thyroid Storm.
Article in JCEM case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thyroid storm describes a rare, life-threatening hypermetabolic state characterized by an excessive activation of the sympathetic nervous system and heightened sensitivity to circulating catecholamines. We present a case of thyroid storm with severe dilated cardiomyopathy (DCM) and cardiogenic shock. A 39-year-old woman with a history of hyperthyroidism was admitted following ventricular fibrillation arrest and cardiogenic shock requiring extracorporeal membrane oxygenation (ECMO) support. Clinical findings included proptosis, diffuse thyromegaly, acute kidney injury, shock liver, severe metabolic acidosis, and a severely dilated heart with an ejection fraction of 17%. Thyroid function tests confirmed Graves disease. The patient was treated with methimazole, hydrocortisone, and cholestyramine. Her condition improved, enabling successful weaning from ECMO and vasopressors with recovery of cardiac function. The patient was discharged to rehabilitation on heart failure therapy and methimazole, with follow-up arranged. This case highlights the rare occurrence of DCM secondary to thyroid storm, underscoring the importance of early recognition and treatment. Thyrotoxicosis can lead to significant cardiac dysfunction, but timely intervention can reverse myocardial damage and improve outcomes. This report emphasizes the need for individualized treatment approaches, especially in cases complicated by coexisting conditions such as hepatic dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.